MIMIC: Mirror Box Therapy as a Treatment Option for Functional Movement Disorders

Sponsor
The Cleveland Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03660098
Collaborator
(none)
14
1
60.1
0.2

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized that a brief, single, in-office mirror therapy session will lead to a noticeable decrease in FMD-related involuntary movements.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients diagnosed with Functional Movement Disorder presenting with a unilateral or asymmetrical bilateral hand tremor will be asked to participate in a series of hand exercises with and without a mirror box. The severity of the tremor will be rated subjectively by the subject and objectively by the neurologist after hand exercises with and without the mirror box.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    14 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Mirror Box Therapy as a Treatment Option for Functional Movement Disorders
    Actual Study Start Date :
    Jun 28, 2018
    Anticipated Primary Completion Date :
    Jun 1, 2023
    Anticipated Study Completion Date :
    Jul 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Change in Simplified Functional Movement Disorders Rating Scale (s-FMDRS) score post exercise [Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 14 subjects and completing analysis with projected finish date in 1 year]

      The difference in scored movement severity in the more affected hand based on the modified s-FMDRS scale during the Unified Parkinson's Disease Rating Scale (UPDRS) exam after the exercises with vs. without the mirror box. Movements are scored by video raters on a scale of 0-3, and higher score indicates more severe movement.

    Secondary Outcome Measures

    1. Change in Simplified Functional Movement Disorders Rating Scale (s-FMDRS) score during exercise [Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 14 subjects and completing analysis with projected finish date in 1 year]

      The difference in scored movement severity in the more affected hand based on the modified s-FMDRS scale with vs. without the mirror box during exercise. Movements are scored by video raters on a scale of 0-3, and a higher score indicates more severe movement.

    2. Change in self-perception [Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 14 subjects and completing analysis with projected finish date in 1 year]

      The difference in patient self-perception of movement severity based on a self-perception scale after the task with vs. without the mirror box. Patient scores movement on a scale of 0-4, with a higher score indicating more severe movement.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients diagnosed with functional movement disorder by a fellowship trained movement disorders neurologist, presenting predominantly with unilateral or asymmetrical bilateral involuntary movement in the upper extremity

    2. In patients with bilateral involuntary movements, the symptoms in one arm must be minimal

    Exclusion Criteria:
    1. Patients with moderate to severe involuntary movement in both arms

    2. Significant cognitive impairment that prevents proper informed consent

    3. Severe involuntary movement that interferes with the use of the apparatus

    4. Patients with hemiparesis or the loss of one arm due to various reasons (e.g. amputations, birth defects, etc.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cleveland Clinic Cleveland Ohio United States 44195

    Sponsors and Collaborators

    • The Cleveland Clinic

    Investigators

    • Principal Investigator: Xin Xin Yu, MD, The Cleveland Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Xin Xin Yu, MD, Attending Physician, The Cleveland Clinic
    ClinicalTrials.gov Identifier:
    NCT03660098
    Other Study ID Numbers:
    • 18-458
    First Posted:
    Sep 6, 2018
    Last Update Posted:
    Aug 4, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xin Xin Yu, MD, Attending Physician, The Cleveland Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 4, 2022